Fate Of IRA Negotiations Uncertain After Trump Election Victory

President-elect Donald Trump has won a second term without articulating a concrete plan for how he would lower prescription drug costs in America, placing Biden administration policies to rein in high drug prices, including Medicare drug price negotiations under the Inflation Reduction Act (IRA), on shaky ground. Trump is expected to revive some policies from his first term, while others will likely fall by the wayside. What’s at stake The IRA passed in 2022 without a single Republican vote...